Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.
Clinical trial NCT05301465 · UNKNOWN
Trial details
- NCT number
- NCT05301465
- Sponsor
- University of Pisa
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-01
- Primary completion
- 2022-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.